GlassScriptPhysician profile
John Schrock
NPI 1619553005
$2,880.19
in general payments reported to CMS, 2019-2025
14 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $240 · 2024: $1,394 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,743 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,743.18 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $468.42 | 2024-2025 | |
| Stryker Corporation | $407.88 | 2023-2025 | Pangea, Triathlon, Accolade |
| Depuy Synthes Sales INC. | $297.84 | 2024-2025 | Na, Motoband Cp, Fibergraft Bg Morsels |
| Polynovo North America LLC | $296.27 | 2024-2025 | Novosorb Btm |
| Boston Scientific Corporation | $254.86 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Smith+Nephew, INC. | $214.41 | 2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium, Spatial Frame |
| Innovation Technologies INC | $139.88 | 2025 | Irrisept |
| Medical Device Business Services, INC. | $137.01 | 2024 | |
| Orthofix Medical, INC. | $136.57 | 2024 | Spinal-Stim |
| Abbott Laboratories | $127.28 | 2024 | Eterna |
| Heron Therapeutics, INC. | $121.74 | 2023 | Zynrelef |
| Cosa Medical, LLC | $117.19 | 2025 | |
| Axogen | $88.93 | 2025 | |
| Medtronic, INC. | $71.91 | 2025 | Unid_pass |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schrock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.